PTTG3P and cancer: In addition, PTTG3P had significant prognosis value in patients with different cancers, including KIPAN, BRCA, KICH, KIRC, COADREAD, ESCA, LIHC, LUAD, LUSC, KIRP, and PRAD (all p < 0.05, Supplementary Table S2).